Company page

Arvinas, Inc.

Arvinas, Inc. is a public company traded under the ticker ARVN in the American market. The company has a market capitalization of approximately $518 million. Arvinas focuses on developing innovative therapies for various diseases using its proprietary protein degradation technology.